Weiboxin Biotechnology | Supporting the Successful Convening of the International Symposium on Porcine Gastrointestinal Diseases

From April 9 to 11, the inaugural International Symposium on Porcine Gastrointestinal Diseases was held in Nanyang. Muyuan Group The conference was held with great pomp and ceremony. Focusing on ileitis, it drew numerous experts from both China and abroad, including the Director of Aquaculture Technology, who attended to learn and exchange ideas. Guangzhou Weiboxin Biotechnology Co., Ltd. (hereinafter referred to as Weiboxin) We were invited to attend the seminar, which was a complete success.

This conference comprises a pre-conference forum and two days of specialized sessions on ileitis, covering topics such as porcine epidemic diarrhea (PED), porcine rotavirus disease, Escherichia coli, Salmonella, and ileitis. Renowned experts from both China and abroad have been invited to engage in in-depth academic exchanges and discussions on the pathogens and epidemiology of these diseases, pathogen–host interactions, diagnostics and prevention, clinical practice, and research advances. In addition, leading companies have been invited to present their production-based prevention and control strategies and practical experiences, garnering significant attention. 
 

Weiboxin is a high-tech enterprise specializing in the R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. Its product portfolio covers Molecular diagnostics and Immunoassay and other fields, thereby meeting the market’s diverse needs. During the exhibition, the company showcased several star products, such as PCR detection reagents, lyophilized reagents, ELISA reagents, and nucleic acid extraction reagents for porcine diarrhea , attracting the attention and inquiries of exhibition visitors.

Single-plex PCR: Porcine Epidemic Diarrhea Virus Nucleic Acid Detection Kit (Fluorescent PCR Method), Porcine Transmissible Gastroenteritis Virus Nucleic Acid Detection Kit (Fluorescent PCR Method), Porcine Group A Rotavirus Nucleic Acid Detection Kit (Fluorescent PCR Method)

Double PCR: Porcine Epidemic Diarrhea Virus/Porcine Infectious Gastroenteritis Nucleic Acid Detection Kit (Dual-Fluorescence PCR), Porcine Epidemic Diarrhea Virus/Porcine Delta Coronavirus Nucleic Acid Detection Kit (Dual-Fluorescence PCR), Porcine Epidemic Diarrhea Virus/Porcine Group A Rotavirus Nucleic Acid Detection Kit (Dual-Fluorescence PCR), and others. 
 

Multiplex PCR: Nucleic acid detection kits for porcine epidemic diarrhea virus, porcine group A rotavirus, and porcine deltacoronavirus (triple-fluorescence PCR method); nucleic acid detection kit for porcine epidemic diarrhea virus, transmissible gastroenteritis virus, and porcine group A rotavirus (triple-fluorescence PCR method); and nucleic acid detection kit for porcine epidemic diarrhea virus, transmissible gastroenteritis virus, porcine group A rotavirus, and porcine deltacoronavirus (quadruple-fluorescence PCR method), among others.

ELISA: Porcine Transmissible Gastroenteritis Virus ELISA Antibody Detection Kit, Porcine Epidemic Diarrhea Virus (IgA) ELISA Antibody Detection Kit

At this conference, Weiboxin also fully showcased R&D Capabilities and Expertise Weiboxin places great emphasis on independent R&D and innovation capabilities and has already established a facility that has passed the acceptance inspection of the Ministry of Agriculture and Rural Affairs. GMP production lines for molecular diagnostic products (Class B) and immunological diagnostic products (Class B) It boasts a stable technical team with outstanding independent R&D and innovation capabilities, and maintains close collaborative partnerships with numerous prestigious research institutions both domestically and internationally in the field of R&D.

Guangzhou Weiboxin will continue to dedicate itself to technological innovation, safeguarding animal health. Striving for even greater achievements, Weiboxin Biotechnology steadfastly upholds “ Professional testing for animal epidemics; technology-driven healthy farming. With a corporate mission to “drive value through technology,” the company has consistently adhered to this core business philosophy and wholeheartedly supported the convening of the IPDDS International Symposium on Porcine Digestive Tract Diseases, thereby contributing to the advancement and development of the industry.

When looking for animal disease testing reagents, choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-66377266 / 135 3988 6748, Ms. Dai

Guangzhou Weiboxin Biotechnology Co., Ltd. is located in the national-level innovation park—Guangzhou Science City. The company is a provincial-level “Little Giant” high-tech enterprise specializing in the forward R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. It has been recognized as a “Contract-Honoring and Credit-Keeping Enterprise” by Guangdong Province and as a provincial demonstration unit for intellectual property. Additionally, it serves as an industry–university–research collaboration base for Guangdong Food and Drug Vocational College and as an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. The company has been designated as an innovative, high-potential enterprise by multiple research institutes, including the Entrepreneurship College of Jinan University in Guangdong Province, and has been awarded the titles of “Specialized, Refined, Distinctive, and Innovative” enterprise at both municipal and provincial levels. It has also received the “Most Investment-Valuable Enterprise” award and the annual title of “ASF and Swine Disease Testing Service Provider.” Furthermore, its veterinary drug product has been granted an approval number by the Ministry of Agriculture and Rural Affairs: Veterinary Drug Registration No. 191438923 (African Swine Fever Virus Fluorescent PCR Diagnostic Kit). The company was awarded the Excellence Prize in the Growth Category of the Biopharmaceutical Industry at the 11th China Innovation and Entrepreneurship Competition, the Provincial Second Prize in the Growth Category of the Nanotechnology Industry Technology Competition, and the National Third Prize in the Growth Category of the National Finals of the Nanotechnology Industry Technology Innovation Special Competition within the China Innovation and Entrepreneurship Competition. It has consecutively received the A-Level Tax Credit Honor Certificate, the Four-Star Trademark Brand Certification, and the Two-Integration Management System Assessment Certificate each year. In addition, it holds ISO 9001 International Quality Management System Certification, ISO 14001 International Environmental Management System Certification, and GMP certification from the Ministry of Agriculture. Since its establishment, the company has been granted a total of 24 patents, including 5 invention patents, 15 utility model patents, and 4 design patents, as well as more than ten trademarks.

The company boasts robust technical capabilities and a team of world-class professionals, including dozens of masters, doctors, and returnees who studied abroad, as well as numerous senior-title technical experts. Currently, the company’s primary focus is on the research and development of molecular diagnostic reagents. Its core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, including public-health–oriented fluorescent PCR test kits, animal disease–control–oriented fluorescent PCR test kits, clinical and research–grade fluorescent quantitative PCR kits, and transgenic identification test kits (ZL2006). The company has also established a nationwide distribution network covering over ten major cities, such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao.

Looking ahead, Weiboxin will remain steadfast in its commitment to continuously enhance product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, we will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advancing life sciences. Quality is our lifeline; innovation is our soul. Upholding this guiding principle, we will relentlessly strive to become the premier supplier of rapid diagnostic reagents and instruments.